Former Mt. Gox CEO Mark Karpeles makes his comeback
Quick Take Former Mt. Gox CEO Mark Karpeles is making his comeback to crypto with the launch of a new exchange, EllipX.
Episode 7 of The Crypto Beat was recorded with The Block's Editor-In-Chief Tim Copeland and Former Mt. Gox CEO Mark Karpeles.
Listen below, and subscribe to The Crypto Beat on YouTube , Apple , Spotify , Twitch or wherever you listen to podcasts. Please send feedback and revision requests to [email protected]
Former Mt. Gox CEO Mark Karpeles joined Tim Copeland to discuss his return to the crypto space with the launch of a new exchange: EllipX.
OUTLINE
00:00 Introduction
04:37 - Another exchange?
6:20 - Trust issues
12:44 - Why Europe?
15:15 - Security features
17:55 - FTX collapse opens the market
25:09 - Post-FTX collapse
31:54 - Ungox
36:47 - Mt Gox repayments
40:38 - Closing thoughts
The Block Community
The Block is launching a new community experience for fans of The Scoop! Follow us on Lens to stay in the loop: hey.xyz/u/theblockcommunity
The Block Newsletters
The Block's newsletters bring you the latest news and analysis of the fast-moving crypto and DeFi markets. To subscribe, visit theblock.co/newsletters
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Qualcomm (QCOM.US) Snapdragon Summit Preview: 2nm Dual-Chip Debuts, AI Diversification Narrative Faces Key Verification
Qualcomm is scheduled to hold its annual Snapdragon Summit in Maui, Hawaii, from September 22 to 24 local time.
SUI SuperTrend Flips to Buy — Macro Shift From Bearish to Bullish Begins
Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.
STONK hits new highs after erasing 27% crash
Crypto prices
More
